Alzheimer's Disease clinical trials
Showing 151–200 of 331 active trials. Describe your situation to see which ones you may be eligible for.
- Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- Cognitive Neurology Unit Clinical Registry
- Tau Networks in Psychotic Alzheimer's Disease
- Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Imaging Biomarkers in Preclinical and Symptomatic AD
- Alzheimer Prevention Trials (APT) Webstudy
- Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Dominantly Inherited Alzheimer Network (DIAN)
- Alzheimer's Disease Genetics Study
- Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
- Low-Dose Radiotherapy for Alzheimer's Disease
- Alzheimer's Tau Platform: Master Protocol
- Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Moving Yourself in Space and Time: MYSTIC
- Neural Control of Gait & Navigation in ADRD
- Crownlands Observing Progression With Neurons Study
- ADRC Clinical Cohort (Alzheimer's Disease)
- Swallowing Impairments in Adults With and Without Alzheimer's Disease
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Study to Understand Novel Biomarkers in Researching Dementia
- Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
- A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- Tennessee Alzheimer's Project
- Alzheimer"s Imaging Biomarkers in Obesity
- Late Onset Alzheimer's Disease
- Genetic Studies of Early-onset Dementia
- Autoimmune Features of Neurodegenerative Disorders
- OCT Angiography and NRAI in Dementia
- Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
- Wake Forest Alzheimer's Disease Clinical Core
- Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- F 18 T807 Tau PET Imaging of Alzheimer's Disease
- University of Central Florida CereBank
- NYSCF Scientific Discovery Biobank
- Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
- UPenn Observational Research Repository on Neurodegenerative Disease
- Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
- Longitudinal Cognitive Assessment by BoCA
- DC Longitudinal Study on Aging and Specimen Bank
- Retinal Imaging in Neurodegenerative Disease
- Novel Glaucoma Diagnostics
- Mindfulness to Enhance Cognitive Health in Latino Older Adults
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.